Post-approval studies (Phase 4)Active Not RecruitingNCT07219121
What this trial is testing
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Who this might be right for
ProteinuriaImmunoglobulin A (IgA) NephropathyFocal Segmental Glomerulosclerosis+1 more
Travere Therapeutics, Inc. 20